scispace - formally typeset
S

S Sandra Loerakker

Researcher at Eindhoven University of Technology

Publications -  63
Citations -  1926

S Sandra Loerakker is an academic researcher from Eindhoven University of Technology. The author has contributed to research in topics: Medicine & Notch signaling pathway. The author has an hindex of 21, co-authored 55 publications receiving 1432 citations. Previous affiliations of S Sandra Loerakker include Stanford University.

Papers
More filters
Journal ArticleDOI

Pressure Induced Deep Tissue Injury Explained

TL;DR: A multi-scale approach was adopted using model systems ranging from single cells in culture, tissue engineered muscle to animal studies with small animals, which led to a clear understanding on two damage mechanisms associated with the development of DTI.
Journal ArticleDOI

The effects of deformation, ischemia, and reperfusion on the development of muscle damage during prolonged loading

TL;DR: The results imply that deformation, ischemia, and reperfusion all contribute to the damage process during prolonged loading, although their importance varies with time.
Journal ArticleDOI

Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model

TL;DR: The hypothesis that integration of a computationally inspired heart valve design into TE methodologies could guide tissue remodeling toward long-term functionality in tissue-engineered heart valves (TEHVs) is tested and suggests the relevance of an integrated in silico, in vitro, and in vivo bioengineering approach as a basis for the safe and efficient clinical translation of TEHVs.
Journal ArticleDOI

Compression-induced damage and internal tissue strains are related

TL;DR: It is shown that there is a reproducible monotonic increase in damage with increasing maximum shear strain once a strain threshold has been exceeded, confirming that tissue deformation per se is important in the aetiology of deep tissue injury.
Journal ArticleDOI

Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity

TL;DR: An unmet clinical need remains for valve replacements with regenerative, remodelling and growth potential, and next-generation tissue-engineered heart valves (TEHVs) are a promising therapeutic option for patients with valvular heart disease.